1. Home
  2. Labeler Index
  3. Bionpharma Inc.
  4. 69452-125
  5. NDC Package Code: 69452-125-50 Oxcarbazepine

NDC Package 69452-125-50 Oxcarbazepine

Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69452-125-50
Package Description:
1 BOTTLE, GLASS in 1 CARTON / 250 mL in 1 BOTTLE, GLASS
Product Code:
69452-125
Proprietary Name:
Oxcarbazepine
Non-Proprietary Name:
Oxcarbazepine
Substance Name:
Oxcarbazepine
Usage Information:
Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).
11-Digit NDC Billing Format:
69452012550
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 283536 - oxacarbazepine 300 MG in 5 mL Oral Suspension
  • RxCUI: 283536 - oxcarbazepine 60 MG/ML Oral Suspension
  • RxCUI: 283536 - oxacarbazepine 300 MG per 5 ML Oral Suspension
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Bionpharma Inc.
    Dosage Form:
    Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • OXCARBAZEPINE 300 mg/5mL
    • Pharmacologic Class(es):
  • Anti-epileptic Agent - [EPC] (Established Pharmacologic Class)
  • Decreased Central Nervous System Disorganized Electrical Activity - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    ANDA209652
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    02-14-2023
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 69452-125-50?

    The NDC Packaged Code 69452-125-50 is assigned to a package of 1 bottle, glass in 1 carton / 250 ml in 1 bottle, glass of Oxcarbazepine, a human prescription drug labeled by Bionpharma Inc.. The product's dosage form is suspension and is administered via oral form.

    Is NDC 69452-125 included in the NDC Directory?

    Yes, Oxcarbazepine with product code 69452-125 is active and included in the NDC Directory. The product was first marketed by Bionpharma Inc. on February 14, 2023 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 69452-125-50?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 69452-125-50?

    The 11-digit format is 69452012550. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-269452-125-505-4-269452-0125-50